E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/13/2005 in the Prospect News Biotech Daily.

New Issue: Stem Cell Sciences prices £6 million IPO at 97p

New York, July 13 - Stem Cell Sciences plc priced its initial public offering of common stock at 97p per share, raising £6 million.

Colins Stewart plc was manager for the sale.

Stem Cell Sciences will be listed on the Alternative Investment Market under the ticker "STEM," with trading expected to start on July 18.

The IPO values the company at £21 million, according to an announcement from BioTech Capital, which owns 2.4 million shares of Stem Cell Sciences.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.